These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24685577)

  • 21. Chronic myeloid leukaemia with BCR-ABL fusion genes located to both chromosomes 9, cyclic leukocytosis and nodal T-lymphoblastic transformation--durable complete remission following imatinib therapy.
    Dufva IH; Karle H; Brondum-Nielsen K; Andersen MK; Madsen HO; Johnsen HE
    Leukemia; 2005 Apr; 19(4):671-3. PubMed ID: 15703782
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical, morphological, cytogenetic and molecular aspects of a series of Ph-negative chronic myeloid leukemias.
    Aurich J; Duchayne E; Huguet-Rigal F; Bauduer F; Navarro M; Perel Y; Pris J; Caballin MR; Dastugue N
    Hematol Cell Ther; 1998 Aug; 40(4):149-58. PubMed ID: 9766919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A molecular cytogenetic study on chromosome anomalies of chronic myeloid leukemia].
    Zhu B; Shen X; Li C; Lai X; Li Y; Shi K; Feng H; Wang R
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):116-8. PubMed ID: 10751535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Fluorescent in-situ hybridization technique (FISH) in the diagnosis of Philadelphia translocation in chronic myeloid leukemia].
    Martinet D; Mühlematter D; Jotterand Bellomo M
    Schweiz Med Wochenschr; 1996 May; 126(20):855-63. PubMed ID: 8685681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to Imatinib mesylate in chronic myeloid leukemia patients with variant BCR-ABL fusion transcripts.
    Sharma P; Kumar L; Mohanty S; Kochupillai V
    Ann Hematol; 2010 Mar; 89(3):241-7. PubMed ID: 19714331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discontinuation of imatinib therapy after achievement of complete molecular response in a Ph(+) CML patient treated while in long lasting complete cytogenetic remission (CCR) induced by interferon.
    Breccia M; Diverio D; Pane F; Nanni M; Russo E; Biondo F; Frustaci A; Gentilini F; Alimena G
    Leuk Res; 2006 Dec; 30(12):1577-9. PubMed ID: 16630657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec). Bone marrow histopathology and correlation with genetic status.
    Frater JL; Tallman MS; Variakojis D; Druker BJ; Resta D; Riley MB; Hrisinko MA; Peterson LC
    Am J Clin Pathol; 2003 Jun; 119(6):833-41. PubMed ID: 12817431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
    Matolcsy A
    Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic lymphocytic leukemia after chronic myeloid leukemia in the same patient: two different genomic events and a common treatment?
    D'Arena G; Gemei M; Luciano L; D'Auria F; Deaglio S; Statuto T; Bianchino G; Grieco V; Mansueto G; Guariglia R; Pietrantuono G; Martorelli MC; Villani O; Del Vecchio L; Musto P
    J Clin Oncol; 2012 Nov; 30(32):e327-30. PubMed ID: 23008321
    [No Abstract]   [Full Text] [Related]  

  • 30. bcr/abl mRNA in leukemic blasts of an unusual patient with acute lymphoblastic leukemia followed after 5-year remission by chronic myelogenous leukemia in blast crisis.
    Fujie H; Tsuchiya S; Morita S; Itano M; Yambe T; Ohasi Y; Minegishi N; Minegishi M; Satou T; Konno T
    Leukemia; 1994 Sep; 8(9):1592-5. PubMed ID: 8090037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. e6a2 BCR/ABL1 fusion with cryptic der(9)t(9;22) deletions in a patient with chronic myeloid leukemia.
    Roti G; La Starza R; Gorello P; Gottardi E; Crescenzi B; Martelli MF; Mecucci C
    Haematologica; 2005 Aug; 90(8):1139-41. PubMed ID: 16079118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allogeneic hematopoietic stem cell transplantation: an option for long-term survival for patients with simultaneous appearance of myeloid and lymphatic malignancies.
    Weber T; Ocheni S; Binder M; Theurich S; Scheid C; Schmid C; Müller LP; Christopeit M; Bacher U
    Acta Haematol; 2013; 129(3):135-6. PubMed ID: 23207834
    [No Abstract]   [Full Text] [Related]  

  • 33. [Detection of BCR-ABL1 chimeric gene-positive neutrophils in a patient with mixed phenotype acute leukemia].
    Nagasawa F; Nakamura Y; Tokita K; Takahashi W; Iso H; Arai H; Tsurumi S; Handa T; Nakamura Y; Nakamura Y; Sasaki K; Mitani K
    Rinsho Ketsueki; 2013 Nov; 54(11):2074-8. PubMed ID: 24305542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical and laboratory investigation of pericentric inv(9)(p22q34) with the der(9)t(9;22)(q34;q11) in Ph-positive leukemia].
    Fan Y; Ding SS; Pan JL; Xue YQ; Hu ZH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Apr; 30(2):157-60. PubMed ID: 23568725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fluctuating molecular remission in patients with chronic myeloid leukemia with long term complete cytogenetic response after alpha interferon treatment].
    Casado LF; Picó M; Gómez C; Ferro MT; Fernández-Rañada JM; Steegmann JL
    Med Clin (Barc); 1997 Sep; 109(7):251-5. PubMed ID: 9333689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorescence in situ hybridization for BCR-ABL.
    Drummond MW; Allan EK; Pearce A; Holyoake TL
    Methods Mol Med; 2004; 97():103-16. PubMed ID: 15064488
    [No Abstract]   [Full Text] [Related]  

  • 37. Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript.
    Tchirkov A; Couderc JL; Périssel B; Goumy C; Regnier A; Uhrhammer N; Verrelle P; Berger M
    Leukemia; 2006 Jan; 20(1):167-8. PubMed ID: 16270035
    [No Abstract]   [Full Text] [Related]  

  • 38. Deletions of the 3'BCR and 5'ABL regions in patients with Philadelphia-positive chronic myeloid leukemia: a one-step process occurring in about 10% of the cases without any evidence of genetic instability in the target cells.
    Fournier M; Lacrosse S; Jamar M; Bours V; Herens C
    Cancer Genet Cytogenet; 2005 Jul; 160(2):184-7. PubMed ID: 15993277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolated myelosarcoma development in an adolescent chronic myeloid leukemia patient with t(9;22)(q34;q11.2), +8, +14, +21, and der(1)(p36).
    Oren H; Yilmaz S; Sercan Z; Demircioğlu F; Yüksel E; Irken G
    Cancer Genet Cytogenet; 2008 Apr; 182(1):43-5. PubMed ID: 18328950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of HLA Class I and Class II genes with bcr-abl transcripts in leukemia patients with t(9;22) (q34;q11).
    Mundhada S; Luthra R; Cano P
    BMC Cancer; 2004 Jun; 4():25. PubMed ID: 15202948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.